CANCIDAS

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, Ireland, Japan, Lithuania, Mexico, Netherlands, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug CANCIDAS contains one active pharmaceutical ingredient (API):

1	Caspofungin UNII VUW370O5QE - CASPOFUNGIN ACETATE
	Caspofungin acetate is a semi-synthetic lipopeptide (echinocandin) compound synthesised from a fermentation product of Glarea lozoyensis. Caspofungin acetate inhibits the synthesis of beta (1,3)-D-glucan, an essential component of the cell wall of many filamentous fungi and yeast. Beta (1,3)-D-glucan is not present in mammalian cells.
	Read more about Caspofungin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CANCIDAS Powder for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AX04	Caspofungin	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AX Other antimycotics for systemic use
Discover more medicines within J02AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	525500301155311, 525500302151318
CA	Health Products and Food Branch	02244265, 02244266
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	30028-11-11, 30033-11-11
EE	Ravimiamet	1087477, 1092169
ES	Centro de información online de medicamentos de la AEMPS	01196001, 01196003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	006079, 006115
GB	Medicines & Healthcare Products Regulatory Agency	48475
JP	医薬品医療機器総合機構	6179402D1020, 6179402D2026
LT	Valstybinė vaistų kontrolės tarnyba	1007521, 1028063
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	555M2000
NG	Registered Drug Product Database	B4-9092, B4-9093
NL	Z-Index G-Standaard, PRK	70300, 70319
PL	Rejestru Produktów Leczniczych	100126880, 100126896
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64792001, W64793001
SG	Health Sciences Authority	11762P, 11763P
TN	Direction de la Pharmacie et du Médicament	7013131H, 7013132H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699636260203, 8699636260227
US	FDA, National Drug Code	0006-3822, 0006-3823
ZA	Health Products Regulatory Authority	37/20.2.2/0544, 37/20.2.2/0545